Structure based identification of first-in-class fragment inhibitors that target the NMN pocket of M. tuberculosis NAD+-dependent DNA ligase A.

Journal of Structural Biology
Ankita ShuklaRavishankar Ramachandran

Abstract

NAD+-dependent DNA ligase (LigA) is the essential replicative ligase in bacteria and differs from ATP-dependent counterparts like the human DNA ligase I (HligI) in several aspects. LigA uses NAD+ as the co-factor while the latter uses ATP. Further, the LigA carries out enzymatic activity with a single divalent metal ion in the active site while ATP-dependent ligases use two metal ions. Instead of the second metal ion, LigA have a unique NMN binding subdomain that facilitates the orientation of the β-phosphate and NMN leaving group. LigA are therefore attractive targets for new anti-bacterial therapeutic development. Others and our group have earlier identified several LigA inhibitors that mainly bind to AMP binding site of LigA. However, no inhibitor is known to bind to the unique NMN binding subdomain. We initiated a fragment inhibitor discovery campaign against the M. tuberculosis LigA based on our co-crystal structure of adenylation domain with AMP and NMN. The study identified two fragments, 4-(4-fluorophenyl)-4,5,6,7-tetrahydro-3H imidazo[4,5-c] pyridine and N-(4-methylbenzyl)-1H-pyrrole-2-carboxamide, that bind to the NMN site. The fragments inhibit LigA with IC50 of 16.9 and 28.7 µM respectively and exhibit MIC of ~20 an...Continue Reading

References

Apr 15, 1976·Nature·S Söderhäll
Nov 29, 1974·Science·I R Lehman
Dec 23, 1994·Science·A Sancar
Jun 11, 1998·Emerging Infectious Diseases·A RattanN Ahmad
Jan 8, 1999·Journal of Molecular Biology·D J Timson, D B Wigley
Jun 16, 1999·Structure·M R SingletonD B Wigley
Oct 30, 1999·Antimicrobial Agents and Chemotherapy·G CiarrocchiL Tilley
Aug 18, 2000·Mutation Research·D J TimsonD B Wigley
Nov 1, 2000·Nucleic Acids Research·A J Doherty, S W Suh
Jul 10, 2001·Molecular Microbiology·A WilkinsonR Bowater
Jul 19, 2001·The Journal of Biological Chemistry·V SriskandaS Shuman
Jul 18, 2003·The Journal of Biological Chemistry·Heike Brötz-OesterheltHarald Labischinski
Feb 27, 2004·The Journal of Biological Chemistry·Chunling GongStewart Shuman
Nov 27, 2004·Nature·John M PascalTom Ellenberger
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Pavol SkubákNavraj S Pannu
Dec 8, 2004·Microbiology·Manuel Lavesa-CurtoRichard P Bowater
Dec 20, 2005·Nucleic Acids Research·Sandeep Kumar SrivastavaRavishankar Ramachandran
Jul 18, 2006·Virology·Delphine Benarroch, Stewart Shuman
May 1, 2007·Molecular Cell·Jayakrishnan NandakumarStewart Shuman
Jun 6, 2007·Antimicrobial Agents and Chemotherapy·Malgorzata Korycka-MachalaJarosław Dziadek
Nov 8, 2008·The Lancet Infectious Diseases·Mandeep Jassal, William R Bishai
Mar 31, 2009·The Journal of Biological Chemistry·Stewart Shuman
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Dec 30, 2010·Antimicrobial Agents and Chemotherapy·Scott D MillsSuzanne S Stokes
Jul 2, 2011·Bioorganic & Medicinal Chemistry Letters·Suzanne S StokesScott D Mills
May 10, 2012·Journal of Computer-aided Molecular Design·Russell Spitzer, Ajay N Jain
May 16, 2012·Antimicrobial Agents and Chemotherapy·Steven D PodosMichael J Pucci
Aug 25, 2012·Sub-cellular Biochemistry·Timothy R L Howes, Alan E Tomkinson
Jun 26, 2013·Acta Crystallographica. Section D, Biological Crystallography·Philip R Evans, Garib N Murshudov
Nov 30, 2013·Bioorganic & Medicinal Chemistry Letters·Kerry Murphy-BenenatoP Ann Boriack-Sjodin
Oct 30, 2015·Proceedings of the National Academy of Sciences of the United States of America·Mihaela-Carmen UnciuleacStewart Shuman
Apr 14, 2016·Trends in Microbiology·Vegard Eldholm, François Balloux
Sep 2, 2016·Bioscience Reports·Giulia PergolizziRichard Peter Bowater

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.